Entity

Time filter

Source Type

Malvern, PA, United States

Trademark
Neotropix | Date: 2008-08-12

Pharmaceutical and biological preparations for use in the treatment of cancer. pharmaceutical and biotechnological research and development services.


Neotropix | Entity website

Non-Small Cell Lung Cancer Treatment & Information There are two main types of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). While this document will address some common issues with both types, the focus will be on non-small cell lung cancer ...


Neotropix | Entity website

Small Cell Lung Cancer Information There are two main types of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). While small cell carcinoma may develop from other regions of the body, it most commonly originates in the lung ...


Neotropix | Entity website

Neotropix Announces Expansion of On-going Clinical Trial for Adult Neuroendocrine Cancers Receives Orphan Drug Designation for NTX-010 from the FDA Malvern, PA, October 8, 2008 Neotropix, Inc., a clinical-stage development company focused on neuroendocrine cancer treatments, announced today that it has begun enrolling neuroendocrine cancer patients into an expanded clinical trial of its lead candidate, NTX-010 (SVV-001), a tumor-selective naturally-occurring oncolytic virus ...


Neotropix | Entity website

Discover hidden collaborations